发明名称 EPIGENETIC MARKER FOR THE IDENTIFICATION OF IL17 POSITIVE T CELLS IN COMPLEX SAMPLES
摘要 The present invention relates to a method, in particular an in vitro method for identifying IL-17 expressing T cells in a blood and/or tissue sample derived from a mammal, comprising analysing the methylation status of at least one CpG position in the gene IL-17A, wherein a demethylation of said at least one CpG position in said sample when compared to an analogous position in a non IL-17 blood cell is indicative for a IL-17 positive CD4 positive T cell. The analyses according to the invention can identify IL-17 positive T cells and distinguish them from all other cells in complex samples, such as, for example, other blood cells. The present invention furthermore provides an improved method for quantifying IL-17 positive T cells in complex samples based on a comparison of the IL-17A methylation with a methylation of at least one marker selected from the group of CD3, FOXP3, and/or GAPDH. The method can be performed without a step of purifying and/or enriching cells, preferably in whole blood and/or non-trypsinized tissue.
申请公布号 US2014227703(A1) 申请公布日期 2014.08.14
申请号 US201214350234 申请日期 2012.10.18
申请人 Epiontis GmbH 发明人 Olek Sven;Baron Udo
分类号 C12Q1/68 主分类号 C12Q1/68
代理机构 代理人
主权项 1. A method for identifying IL-17 positive CD4 positive T cells in a blood and/or tissue sample derived from a mammal, comprising analysing the methylation status of at least one CpG position in gene IL-17A, wherein a demethylation of said at least one CpG position in said sample when compared to an analogous position in a non IL-17 blood cell is indicative for an IL-17 positive CD4 positive T cell.
地址 Berlin DE